Zhao, Ying
Yang, Yuan-Yuan
Yang, Bao-Lin
Du, Ya-Wei
Ren, Da-Wei
Zhou, Hong-Mei
Wang, Jing
Yang, Hui-Min
Wang, Yao-Xian
Zhang, Ying-Ying
Wu, Sheng-Xian http://orcid.org/0000-0002-6034-9728
Funding for this research was provided by:
Major National Science and Technology Project (2017ZX09304019)
Article History
Received: 16 May 2019
Accepted: 6 January 2021
First Online: 22 January 2021
Ethics approval and consent to participate
: This study was planned according to the Declaration of Helsinki and relevant clinical trial research norms and laws. Ethics approval for this trial protocol has been obtained from the Ethics Committee of DHABUCM (No. DZMEC-KY-2018-47). Patients will be provided with sufficient time to consider whether to enter the trial or not. The investigators and research assistants must obtain the written informed consent from each participant before randomization. On the consent form, participants will be asked if they agree to the use of their data should they choose to withdraw from the trial. Participants will also be asked for permission for the research team to collect the biological specimens and use the data in ancillary studies. Signed informed consent form should be preserved properly by researchers and participants independently. The consent materials and form are available from the corresponding author on request. Participation in this study is strictly confidential. Any information that is published will not reveal the identity of the subjects.
: All authors have reviewed the final version of the manuscript and approved its publication.
: The authors declare that they have no competing interests.